 SANTA MONICA, Calif., Sept. 15, 2021 GLOBE NEWSWIRE -- BioVie Inc., NASDAQ: BIVI BioVie or the Company a clinical-stage company developing innovative drug therapies for the treatment of neurodegenerative disorders and advanced liver disease, today announced the participation of its management team in the Oppenheimer Fall Healthcare Life Sciences MedTech Virtual Summit September 22, 2021. 